Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ge Yu

Showing results (331-340 of 349) with videos related to

Pageof 35
Sort By:
Biomed Research International|August 19, 2014
Factors associated with spontaneous clearance of hepatitis C virus in Chinese populationFei Kong, Yu Pan, Xiumei Chi, et al.
European Journal of Medicinal Chemistry|July 15, 2022
A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antiviralsYugendar R Alugubelli, Zhi Zachary Geng, Kai S Yang, et al.
European Journal of Medicinal Chemistry|July 2, 2022
A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antiviralsYuying Ma, Kai S Yang, Zhi Zachary Geng, et al.
Nature Communications|June 1, 2019
Position and orientation of the westerly jet determined Holocene rainfall patterns in ChinaUlrike Herzschuh, Xianyong Cao, Thomas Laepple, et al.
Antiviral Research|March 30, 2024
Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitorsKaustav Khatua, Yugendar R Alugubelli, Kai S Yang, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
An Azapeptide Platform in Conjunction with Covalent Warheads to Uncover High-Potency Inhibitors for SARS-CoV-2 Main ProteaseKaustav Khatua, Yugendar R Alugubelli, Kai S Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2025
Porustobart (HBM4003) plus toripalimab as second-line therapy in patients with advanced hepatocellular carcinoma: a multicenter, open-label, phase I studyNingning Zhang, Tian Liu, Ming Luo, et al.
NEJM Evidence|February 6, 2024
A Randomized Trial of PHOTOdynamic Surgery in Non-Muscle-Invasive Bladder CancerRakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al.
Leukemia|March 25, 2018
Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet studyReinhard Stauder, Ge Yu, Karin A Koinig, et al.
Journal of Geophysical Research. Atmospheres : JGR|December 25, 2015
Airborne measurements of organosulfates over the continental U.SJin Liao, Karl D Froyd, Daniel M Murphy, et al.
Pageof 35

Showing results (331-340 of 349) with videos related to

Sort By:
Pageof 35
Biomed Research International|August 19, 2014
Factors associated with spontaneous clearance of hepatitis C virus in Chinese populationFei Kong, Yu Pan, Xiumei Chi, et al.
European Journal of Medicinal Chemistry|July 15, 2022
A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antiviralsYugendar R Alugubelli, Zhi Zachary Geng, Kai S Yang, et al.
European Journal of Medicinal Chemistry|July 2, 2022
A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antiviralsYuying Ma, Kai S Yang, Zhi Zachary Geng, et al.
Nature Communications|June 1, 2019
Position and orientation of the westerly jet determined Holocene rainfall patterns in ChinaUlrike Herzschuh, Xianyong Cao, Thomas Laepple, et al.
Antiviral Research|March 30, 2024
Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitorsKaustav Khatua, Yugendar R Alugubelli, Kai S Yang, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
An Azapeptide Platform in Conjunction with Covalent Warheads to Uncover High-Potency Inhibitors for SARS-CoV-2 Main ProteaseKaustav Khatua, Yugendar R Alugubelli, Kai S Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2025
Porustobart (HBM4003) plus toripalimab as second-line therapy in patients with advanced hepatocellular carcinoma: a multicenter, open-label, phase I studyNingning Zhang, Tian Liu, Ming Luo, et al.
NEJM Evidence|February 6, 2024
A Randomized Trial of PHOTOdynamic Surgery in Non-Muscle-Invasive Bladder CancerRakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al.
Leukemia|March 25, 2018
Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet studyReinhard Stauder, Ge Yu, Karin A Koinig, et al.
Journal of Geophysical Research. Atmospheres : JGR|December 25, 2015
Airborne measurements of organosulfates over the continental U.SJin Liao, Karl D Froyd, Daniel M Murphy, et al.
Pageof 35